AI assistant
Sending…
Xvivo Perfusion — Major Shareholding Notification 2017
Aug 29, 2017
3130_iss_2017-08-29_313a0e32-dfb0-4d02-90c4-a062d918715d.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Xvivo Perfusion Aktiebolag
Holder
Swedbank Robur Fonder AB
Instrument
| Instrument | Aktier SE0004840718 | ||
|---|---|---|---|
| Before the transaction | |||
| Shares | 530,000 | ||
| Voting rights | 530,000 | ||
| Transaction | |||
| Reason for major shareholding notification Buy | |||
| Date | 02/06/2017 | ||
| Limit for number of shares | 5 % | ||
| Limit for number of votes | 5 % | ||
| After the transaction | |||
| Quantity | |||
| Shares | 1,430,000 | ||
| Directly held voting rights | 1,430,000 | ||
| Indirectly held voting rights | 0 | ||
| Percentage | |||
| Directly held shares | 5.51 % | ||
| Directly held voting rights | 5.51 % | ||
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | 5.51 % | 1,430,000 | |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
|||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
|||
| - Physically settled | |||
| - Cash settled | |||
| Total | 5.51 % | 1,430,000 | |
| Published | |||
| 29/08/2017 11:38 | |||
| Contact | |||
| Name | Mia Metso Ekberg | ||
| Phone | 08-58597525 Email [email protected] |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Xvivo Perfusion
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 27
AGM Information
2026
Apr 27
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 22
Annual Report
2026
Apr 1
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Mar 19
Board/Management Information
2026
Feb 20
Regulatory Filings
2026
Feb 20